首页 | 本学科首页   官方微博 | 高级检索  
检索        

依达拉奉治疗急性颅脑损伤的临床研究
引用本文:梁大胜,庞晓军,杜正隆.依达拉奉治疗急性颅脑损伤的临床研究[J].现代预防医学,2012,39(7):1814-1815.
作者姓名:梁大胜  庞晓军  杜正隆
作者单位:广西钦州市第二人民医院ICU,广西钦州,535000
摘    要:目的观察依达拉奉治疗急性颅脑损伤的疗效。方法将60例符合要求的急性颅脑损伤患者,随机分为依达拉奉治疗组30例和常规治疗组(对照组)30例,观察两组脑水肿面积的变化、GCS、APACHE-Ⅱ评分、疗效与预后情况。结果疗程结束后,依达拉奉治疗组和对照组在改善患者脑水肿面积、GCS、APACHE-Ⅱ评分、疗效与预后方面比较,差异均有统计学意义(P﹤0.05)。结论依达拉奉治疗急性颅脑损伤,能够明显减轻脑组织水肿,改善其神经功能缺损,提高疗效和预后。

关 键 词:依达拉奉  急性颅脑损伤

Clinical research of edaravone treatment in acute brain injury
HANG Da-sheng , PANG Xiao-jun , DU Zheng-long.Clinical research of edaravone treatment in acute brain injury[J].Modern Preventive Medicine,2012,39(7):1814-1815.
Authors:HANG Da-sheng  PANG Xiao-jun  DU Zheng-long
Institution:.Intensive Care Unit,Qinzhou City Second People’s Hospital,Qinzhou,Guangxi 535000,China
Abstract:OBJECTIVE To observe treatment efficacy of edaravone in acute brain injury.METHODS 60 patients met the requirements of acute brain injury were randomly divided into 30 cases of edaravone treatment group and the conventional treatment group(control group)30 cases.The changes of cerebral edema,GCS,APACHE-Ⅱscore,efficacy and prognosis situation in both groups were observed.RESULTS After treatment,the difference in improving the area of brain edema,GCS,APACHE-Ⅱscore,efficacy and prognosis between edaravone treatment group and control group was significant(P﹤0.05).CONCLUSION Edaravone treatment in acute traumatic brain injury can significantly reduce the brain edema,improve the neurological deficit,the efficacy and prognosis.
Keywords:Edaravone  Acute brain injure
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号